Edges for Sep 27, 2026

A 3 mg THC beverage is very unlikely to remain federally legal to sell on Nov. 16, 2026 under the newly reported hemp rules. I put the Yes probability at 9%, with the market appearing heavily overpricing legalization persistence.

The evidence strongly suggests the San Francisco metro median home value will remain above $1,176,000 on September 30, so the chance of a Yes outcome is low. The market price looks too optimistic for Yes given the recent price level and momentum.

I make Belichick’s chance of being out before Dec. 1, 2026 materially lower than the market suggests. The guaranteed contract and reported administrative support make an immediate exit possible but not the base case.

I make this overwhelmingly likely to resolve Yes. The administration has already experienced multiple Cabinet departures in 2026, and the threshold for the market is only one departure before the January 2027 cutoff.

OpenAI remains a serious contender, but the market price looks optimistic given how quickly the leaderboard has been shifting and how close multiple rivals are to the top. I think OpenAI is slightly more likely than not to finish first, but not by the wide margin implied by the current price.

Rutgers has real on-field pressure on Greg Schiano, but the buyout and lack of any actual administrative move make an early departure far from certain. I think the market is too confident; my independent estimate is that he is out before Feb. 1, 2027 about 65% of the time.

Trump has clearly signaled that the federal government should use a new label for AI, and some official communications may already be shifting in that direction. But the market only resolves Yes if there is a qualifying presidential action or equivalent directive by September 30, and that formal step is still uncertain.

Iliana Iotova appears to be the strongest single candidate and a likely first-round leader, but Bulgaria’s runoff system and a crowded field make the path to an outright win meaningfully less certain than the market price implies. I would still lean Yes, but at a lower probability than 67.5% because consolidation of the anti-Iotova vote in a second round remains the main obstacle.

Avengers: Endgame Encore looks like the narrow favorite to finish first, but the race is close enough that a meaningful upset is still possible. I would price Yes somewhat below the market at 76%, not 82.5%.

I think there is a meaningful chance Trump invokes the Insurrection Act, but it is still far from the base case. My independent estimate is 32%, higher than the market’s 15% because the administration appears willing to escalate in response to protests, immigration unrest, or election-related disorder.

I think a Fed hike by December 31, 2026 is more likely than not, but not nearly as close to certain as the market implies. The hawkish dot plot and recent official commentary make a move plausible, yet three months is still a short window and the Fed usually needs a clean run of data to actually pull the trigger.

Choka Choka is a serious contender, but the category looks close enough that I give it a slight underdog position versus the field. I would price its win chance at 44%, with Bad Bunny and the broader competition keeping the outcome uncertain.

I think there is a meaningful chance the market ends at zero, but it is more likely that at least one qualifying AI announcement will stand in 2026. The OpenAI Navier-Stokes claim makes the zero outcome hard to justify, though uncertainty about qualification and verification keeps it from being near certain.

I think there is a materially better-than-even chance that Congress enacts another debt-limit increase or suspension before Jan. 1, 2027, though the absence of an imminent Treasury deadline keeps it from being close to a certainty. My independent estimate is 41% Yes, which is meaningfully above the market’s 24% price.

Chiang Wan-an remains the frontrunner, but the race has tightened enough that his win is less secure than the current market price implies. I would put his chances in the high-60s rather than near 80%, with the main edge coming from incumbency and a still-slight polling lead.

I think August JOLTS job openings are more likely to stay at or above 7.0 million than fall below it, though the margin is not huge. A modest decline from July is plausible, but the available signals do not point to a large enough drop to make a sub-7.0 million reading the most likely outcome.

Democrats look favored to win the House after the 2026 midterms, but the current market price seems somewhat too optimistic given how far out the election is and how much can still change. My estimate is that Democrats are likely, not close to certain, so I put Yes at 79%.

I think an official Fannie Mae IPO announcement before the market deadline is possible but still unlikely. The balance of evidence favors no announcement, though the political backdrop leaves a meaningful outside chance of a sudden policy-driven shift.

The latest major external forecast sits exactly at the 2.9% threshold, which makes a Yes outcome plausible rather than remote. Still, the IMF often differs from the OECD and may land slightly above 2.9%, so I would rate Yes as a meaningful but not favored outcome.

A 3 mg THC beverage is likely to still qualify as hemp on Nov. 13, 2026 because the broader federal restriction appears to take effect later, around Dec. 11, 2026. The main caveat is that a narrower set of cannabinoid rules may begin earlier, but that does not seem to clearly capture ordinary THC beverages yet.

I think the chance of Franklin Arias playing in an MLB game before Nov. 1, 2026 is low, but not negligible. The most likely outcome is that Boston keeps him in the minors and targets a 2027 debut, with only a small chance of an unexpected late-season call-up.

Canva has not officially announced an IPO yet, but the company is now in the window where a public move becomes plausible within the next few quarters. I think the chance of an official IPO announcement by the end date is meaningfully higher than the market implies, though still far from likely.

I think there is a meaningful but still minority chance that Canada and the EU will formally open negotiations or at least jointly announce that they are moving into a formal negotiation track before year-end. The market looks a bit too skeptical given the political signaling and the upcoming summit, though the legal and institutional hurdles keep this well below even odds.

I put the chance of a reported reopening before Nov. 5, 2026 at 38%. The closure is still being rolled forward weekly with no firm reopening date, which makes a near-term announcement possible but more likely not yet resolved in time.

Ariana Grande has a real path to winning Artist of the Year, but she is not the clear favorite and appears to be running behind Taylor Swift in the market and likely voter sentiment. I would price her at about 39%, slightly above the current market but still closer to a coin-flip outsider than a lock.

Democrats remain narrowly favored, but this is close enough that the market price looks somewhat aggressive. The polling average and some recent surveys support a slight Democratic edge, yet Collins’ incumbency and a strong latest poll keep this from being a comfortable Yes.

The evidence points to an opening weekend above $13 million, with most current tracking clustered in the mid-teens. I think the chance of a sub-$13 million result is meaningfully below the market price implies, though not impossible if the film softens sharply after previews.

I think the market is somewhat overconfident, but still leans Yes because the leading melanoma vaccine candidate has reached positive phase 3 data and sits on a plausible FDA submission path before the deadline. My estimate is a moderately above-even chance of approval by the end of 2027, but not as high as the current market price implies.

The evidence strongly supports Yes: the next Claude Opus model appears to have already debuted as Claude Opus 5.5, and the reported Humanity’s Last Exam scores are well above 45%. The remaining uncertainty is mostly about whether the market intends a different future Opus model, but under the stated rules the observed debut already clears the threshold comfortably.

I think the odds are modestly below the market: there is real legislative attention and bipartisan interest, but converting that into a signed federal law by the end of 2026 is still a high-friction, time-constrained process. My estimate is 18%.

I put the chance at 44% that Trump, Xi, and Putin will meet together before Jan. 1, 2027. The setup is genuinely plausible because there are multiple multilateral venues coming up, but there is still no actual trilateral scheduling and Putin’s attendance remains the key swing factor.

A U.S. military offensive against Iran is already ongoing, but the market’s wording is narrower than mere strikes or hostilities and appears to require an invasion intended to establish control over Iranian territory. Based on that stricter standard and the lack of evidence of a ground-control operation, I assign a low but nonzero chance of Yes.

NVIDIA is still the leader and has a meaningful valuation cushion, but the gap to Apple is not large enough to make the outcome close to certain. I think the market is pricing in a somewhat higher probability than is justified, so I lean Yes but with a materially lower confidence than 74%.

WHOOP is more likely than not to make an IPO announcement eventually, but the odds of an official announcement by the market’s deadline are still modest. I estimate about a 15% chance, above the current market price but still a clear minority outcome.

Jesús Made has a real, but still limited, chance to appear in an MLB game before Nov. 1 because Milwaukee is at least entertaining an emergency postseason role. I think the market is understating that possibility, but the most likely outcome remains that he does not debut this year.

Democrats look favored in North Carolina’s open Senate race, with Roy Cooper holding a consistent polling lead and Republicans showing signs of defensive concern. Still, the market price appears extremely optimistic, and a late Republican recovery is plausible enough that the true probability is meaningfully below the implied level.

Thomas Tuchel is still far more likely than not to remain England manager through the end of 2026, but a 3% dismissal probability looks too low given the normal volatility of international management and the chance that results or internal friction change quickly. I would price the chance of him being out before Jan. 1, 2027 at 10%.

BSD being the next Millennium Prize Problem solved by AI looks possible but not the leading candidate. The current evidence points more strongly to other problems drawing the nearest verified attention, so I would price Yes below the market.

Elon Musk is still posting at a fairly active pace, and the upcoming Starship launch plus ongoing AI and company-related discussion make a sub-40 count less likely than the market favorite implies. I estimate the chance of fewer than 40 qualifying posts over the window at 17%.

I make this a modestly higher-risk event than the market does, with about a 14% chance that at least one cabinet member is impeached before 2027. The main path is a Hegseth impeachment push, either forced by House procedure or unlocked by post-midterm control changes.

The market looks very unlikely to finish below $3.00 by December 31, 2026. Current B200 pricing is still around the high $7 range, and the latest signals point to continued tight supply rather than a collapse in prices.

A trilateral Trump-Zelenskyy-Putin meeting is possible but still unlikely, with the main barrier being Russia’s clear reluctance to commit to any high-level format. I estimate a low-single-digit to low-double-digit chance, centered around 9%.

The market is already pricing a strong chance that Predict.fun’s token launches above a $50M FDV, and that looks broadly plausible given how these launch markets tend to price in a sizable initial valuation. I think the current price is a bit rich, but the Yes outcome still remains the likelier result.

Alibaba has real momentum, but the market’s question is about being number one among Chinese labs at a specific snapshot, and that is a much harder bar than simply having a strong flagship model. I think Alibaba is still more likely than not to miss first place by the end of September, though its chances are higher than the current market price implies.

Alibaba has a credible path to take the lead, but the evidence so far shows ambition and infrastructure rather than an established top spot. The market is close to fair value, and I lean slightly below the current Yes price because rivals can still overtake or retain the lead by the October check.

Kari Lake’s confirmation before Jan. 1, 2027 looks possible but not likely, with the biggest obstacle being the current Senate hold that could prevent a floor vote. I would price it a bit below the market, around 18%, because the nomination appears stalled at exactly the point where calendar risk is becoming severe.

The market is priced near certainty for No, and that looks directionally right because the 5-year yield is still around the high-4% to 5% area, far above the 4.00% trigger. A drop below 4.00% before year-end would require a large, sustained rally in bonds that is not the base case given current rate expectations and recent yield pressure.

The H200 index looks more likely to remain at or above $3.50 than to finish below it on October 31, 2026. Recent pricing trends and announced GPU price increases point upward, although fragmented live listings keep a small chance alive that the finalized index could slip under the threshold.

Marine Le Pen has a credible path to the presidency because she leads the field in first-round polling and benefits from a fragmented opposition, but the two-round system still makes her a substantial underdog relative to her first-round strength. I would price her win at 42%, modestly above the market because her base case is stronger than the crowd may be giving credit for, but still well below even odds due to runoff and legal uncertainty.

The Clarity Act now looks overwhelmingly unlikely to become law in 2026. The Senate’s failed cloture vote is a major procedural barrier, and there is too little time and political momentum left to revive the bill before year-end.

I think the chance the United States acquires any part of Greenland before Jan. 1, 2027 is very low, but not literally zero. The new security agreement points strongly toward expanded U.S. access without any sovereignty transfer, which makes a true acquisition event unlikely.

I put the chance of a Zelenskyy-Putin meeting before Jan. 1, 2027 at 11%. The political and security barriers remain very high, and there is little time for a breakthrough.

Aleksandar Vučić – United Serbia remains the favorite to win the most seats, with both polling and market pricing giving it a clear but not overwhelming edge. The main reason to hesitate is that the opposition is still competitive enough that turnout, tactical coordination, and seat conversion could matter.

Oura has already begun the IPO process and the deal appears to be on a normal late-stage timetable, so an official IPO announcement looks very likely before the market closes. I would price this somewhat below the market but still in the low-to-mid 90s.

A veto override before 2027 looks unlikely, but not impossible if a must-pass bill with unusually broad bipartisan backing is vetoed soon and Congress acts quickly. I put the chance at 6%, slightly below the market.

Recognition is possible but still unlikely absent a major strategic bargain or a clear personal push from Trump. My independent estimate is below the market because the public evidence still points strongly toward the existing One Somalia policy staying in place.

I put Heidi Overton’s chance of being confirmed as FDA Commissioner before Jan. 1, 2027 at 34%. The hearing gives her a path, but the combination of political friction and a very tight remaining calendar makes a timely confirmation less likely than the market’s 38% implies.

I think Bloomberg officially announcing an IPO by the deadline is very unlikely, because there is no credible indication of a filing, a banker-led process, or even a strategic shift toward going public. My independent probability for Yes is 3%.

I put the chance of a UK reversal or formal decision not to transfer Diego Garcia sovereignty at about 20%. The existing transfer framework, if already politically committed, would be difficult to unwind in a few months without a major legal or diplomatic shock.

A nomination before Oct. 1 looks possible but still unlikely; I put the chance at 8%. The reporting supports an active selection process, but not enough concrete evidence that a formal nomination will land within the very short remaining window.